TTNP Historical Earnings image   This TTNP historical earnings page last updated 7/20/2022
TTNP Historical Revenue
PeriodHistorical Earnings DateRevenue
Q1 20225/16/20220.00B
Q4 20213/25/20220.00B
Q3 202111/15/20210.00B
Q2 20218/16/20210.00B
Q1 20215/17/20210.00B
Q4 20203/31/20210.00B
Q3 202011/16/20200.00B
Q2 20208/14/20200.00B
Q1 20205/15/20200.00B
Q4 20193/30/20200.00B
Q3 201911/14/20190.00B
Q2 20198/14/20190.00B
Q1 20195/15/20190.00B
Q4 20184/1/20191.24M
Q3 201811/14/20181.65M
Q2 20188/14/20182.67M
Q1 20185/15/20181.06M
Q4 20174/2/201858000
Q3 201711/9/201740000
Q2 20178/9/201777000
Q1 20175/10/201740000
Q4 20163/16/201735000
Q3 201611/9/201626000
Q2 20168/9/201615.00M
Q1 20165/10/2016NA
Q4 20153/15/2016NA
TTNP Historical Earnings EPS
PeriodHistorical Earnings DateEarnings
Q1 20225/16/2022-0.240
Q4 20213/25/2022-0.260
Q3 202111/15/2021-0.190
Q2 20218/16/2021-0.170
Q1 20215/17/2021-0.280
Q4 20203/31/2021-0.810
Q3 202011/16/2020-1.500
Q2 20208/14/2020-1.500
Q1 20205/15/2020-2.100
Q4 20193/30/2020-2.400
Q3 201911/14/2019-5.400
Q2 20198/14/2019-11.400
Q1 20195/15/2019-10.200
Q4 20184/1/2019-18.600
Q3 201811/14/2018-19.800
Q2 20188/14/2018-7.200
Q1 20185/15/2018-21.600
Q4 20174/2/2018-30.600
Q3 201711/9/2017-36.000
Q2 20178/9/2017-30.600
Q1 20175/10/2017-28.800
Q4 20163/16/2017-27.000
Q3 201611/9/2016-21.600
Q2 20168/9/201699.000
Q1 20165/10/2016-16.200
Q4 20153/15/2016-19.800
Quotes delayed 20 minutes

Email EnvelopeFree TTNP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Titan Pharmaceuticals (TTNP) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

TTOO Historical Earnings
TVTX Historical Earnings
TVTY Historical Earnings
TWST Historical Earnings
TXG Historical Earnings
TXMD Historical Earnings
TYME Historical Earnings
TYRA Historical Earnings
UBX Historical Earnings
UFPT Historical Earnings
What was the record high TTNP historical earnings result?
In terms of earnings or revenue, what is the best TTNP historical earnings result that Titan Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest TTNP historical earnings result was set in Q2 2016, when Titan Pharmaceuticals posted results of 99.000/share. The most successful revenue quarter within our data set was Q2 2016 when Titan Pharmaceuticals reported revenue of 15.00M.

What was the lowest Titan Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest TTNP has reported, and when?

✔️Accepted answer: Within our data set, the lowest TTNP historical earnings result was set in Q3 2017, when Titan Pharmaceuticals posted results of -36.000/share. The smallest revenue quarter within our data set was Q1 2016 when Titan Pharmaceuticals reported revenue of NA.

On this page we presented the TTNP historical earnings date information for Titan Pharmaceuticals. Reviewing that TTNP Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2016, when TTNP posted earnings of 99.000/share. Meanwhile the lowest TTNP historical earnings result was in Q3 2017, when TTNP posted earnings of -36.000/share. Moving to Titan Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2016 when TTNP reported 15.00M in revenue, while the smallest revenue quarter was Q1 2016 when TTNP reported NA in revenue.

For self directed investors doing their due diligence on TTNP or any other given stock, their research can benefit from looking into all of the Titan Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Titan Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for TTNP. Thanks for visiting, and the next time you need to research TTNP historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding TNA, JCI Stock Predictions, Institutional Holders of ABCO.

 

TTNP Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.